Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis

    Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis

    FromKeeping Current

    Start listeningView podcast show

    Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis

    FromKeeping Current

    ratings:
    Length:
    33 minutes
    Released:
    Dec 4, 2023
    Format:
    Podcast episode

    Description

    Do you know what the consequences are of spondyloarthrtitis left untreated? Learn from our experts.    Credit available for this activity expires:  11/30/24  Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998875?ecd=bdc_podcast_libsyn_mscpedu
    Released:
    Dec 4, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.